IGI has partnered with AbbVie to grant exclusive rights to globally develop, manufacture, and commercialise ISB 2001 across North America, Europe, Japan, and Greater China.

Krithivasan highlighted the mixed nature of demand growth for the company, where auto and telecom segments are muted and industrial and tech spending have remained steady.

The resolution failed as the number of votes in favour was less than three times the number of votes against it.

TCS, post-recent underperformance, appears to be attractive trading at 21.5 times FY27 price-to-earnings and in line with its long-term average multiple, Nuvama noted.

The Indian rupee opened weak against the US dollar at 85.83 on Friday, after closing at 85.65 on Thursday. The rupee's ...

According to Bloomberg estimates, DMart's revenue for the June quarter is projected to increase by 17.8% year-on-year, ...

HSBC and Axis Capital are more bullish on its transformative impact and future growth prospects for Glenmark, while Nuvama ...

Macquarie gains comfort from Nair's experience in India, where she has been responsible for various initiatives, including ...

Aditya Birla Money reported a 43.3% year-on-year (YoY) decline in standalone profit after tax to Rs 9.33 crore in Q4FY25 from ...

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.

Aditya Agarwala, head of research and investments at Invest4edu, recommended buying Paytm operator One97 Communications at ...